Literature DB >> 9143550

High glucose reduces generation of plasmin activity by mesangial cells.

E J Fisher1, S V McLennan, D K Yue, J R Turtle.   

Abstract

Mesangium enlargement is a central feature of diabetic nephropathy and almost certainly plays a pathogenic role in this condition. Previous studies have shown that mesangium degradation is reduced in a high glucose mileau. Plasmin has been shown to play an important role in extracellular matrix degradation, both directly and through its ability to activate the matrix metalloproteinases. We therefore investigated how high glucose concentration may affect the various components of the plasminogen cascade on mesangial cells and whether it impairs the ability of the mesangial cell to generate plasmin activity. Result showed decreased binding of plasminogen and the urokinase type plasminogen activator to the mesangial cell surface while the tissue type plasminogen activator and the plasminogen activator-1 associated with mesangial cells were increased. The net effect of these changes was a reduced capacity of mesangial cell layers to generate plasmin activity in a high glucose environment. We postulate that this may be of importance in the reduced mesangium degradation which occurs in diabetes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143550     DOI: 10.1006/mvre.1996.2006

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  10 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

Authors:  M H Poczatek; C Hugo; V Darley-Usmar; J E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Plasminogen activator inhibitor-1 antisense oligodeoxynucleotides abrogate mesangial fibronectin accumulation.

Authors:  Jehyun Park; Ji Yeon Seo; Hunjoo Ha
Journal:  Korean J Physiol Pharmacol       Date:  2010-12-31       Impact factor: 2.016

4.  Abnormalities in signaling pathways in diabetic nephropathy.

Authors:  Frank C Brosius; Charbel C Khoury; Carolyn L Buller; Sheldon Chen
Journal:  Expert Rev Endocrinol Metab       Date:  2010

5.  A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy.

Authors:  Yufeng Huang; Wayne A Border; Ling Yu; Jiandong Zhang; Daniel A Lawrence; Nancy A Noble
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

6.  Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease.

Authors:  M Lassila; K Fukami; K Jandeleit-Dahm; T Semple; P Carmeliet; M E Cooper; A R Kitching
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

7.  Effect of crocin on antioxidant gene expression, fibrinolytic parameters, redox status and blood biochemistry in nicotinamide-streptozotocin-induced diabetic rats.

Authors:  Ioannis Margaritis; Katerina Angelopoulou; Sophia Lavrentiadou; Ilias C Mavrovouniotis; Maria Tsantarliotou; Ioannis Taitzoglou; Alexandros Theodoridis; Aristidis Veskoukis; Efthalia Kerasioti; Dimitrios Kouretas; Ioannis Zervos
Journal:  J Biol Res (Thessalon)       Date:  2020-03-02       Impact factor: 1.889

8.  GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling.

Authors:  Subir Kumar Juin; Sathnur Pushpakumar; Utpal Sen
Journal:  Biomolecules       Date:  2021-10-07

Review 9.  Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.

Authors:  Camelia R Ban; Stephen M Twigg
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus.

Authors:  Chung-Ze Wu; Shih-Hsiang Ou; Li-Chien Chang; Yuh-Feng Lin; Dee Pei; Jin-Shuen Chen
Journal:  Molecules       Date:  2019-11-20       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.